These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8212154)

  • 1. Anemia in renal transplant recipients caused by concomitant therapy with azathioprine and angiotensin-converting enzyme inhibitors.
    Gossmann J; Kachel HG; Schoeppe W; Scheuermann EH
    Transplantation; 1993 Sep; 56(3):585-9. PubMed ID: 8212154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients.
    Gossmann J; Thürmann P; Bachmann T; Weller S; Kachel HG; Schoeppe W; Scheuermann EH
    Kidney Int; 1996 Sep; 50(3):973-8. PubMed ID: 8872973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitor-induced anemia and treatment for erythrocytosis in renal transplant recipients.
    Satoh S; Kaneko T; Seino K; Abe T; Omori S; Sugimura J; Fujioka T; Kubo T
    Nihon Jinzo Gakkai Shi; 1995 Jun; 37(6):343-7. PubMed ID: 7666600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia and angiotensin-converting enzyme inhibition in renal transplant recipients.
    Sizeland PC; Bailey RR; Lynn KL; Robson RA
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S117-9. PubMed ID: 1708009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitor induced anemia in a kidney transplant recipient.
    Kuriyama R; Kogure H; Itoh S; Kikuchi K; Ichikawa N; Nomura Y; Degawa H; Meigata K; Watanabe K; Beck Y; Tomikawa S; Nagao T; Uchida H
    Transplant Proc; 1996 Jun; 28(3):1635. PubMed ID: 8658817
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
    Schmidt A; Gruber U; Böhmig G; Köller E; Mayer G
    Nephrol Dial Transplant; 2001 May; 16(5):1034-7. PubMed ID: 11328912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
    Trivedi H; Lal SM
    Ren Fail; 2003 Jan; 25(1):77-86. PubMed ID: 12617335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia in kidney transplants without erythropoietic agents: levels of erythropoietin and iron parameters.
    Florit EA; Hadad F; Rodriguez Cubillo B; De la Flor JC; Valga F; Perez Flores I; Calvo Romero N; Valero San Cecilio R; Barrientos Guzman A; Sanchez Fructuoso A
    Transplant Proc; 2012 Nov; 44(9):2590-2. PubMed ID: 23146464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalapril-induced anemia in a renal transplant patient.
    Ozbek N; Ozen S; Saatçi U
    Acta Paediatr Jpn; 1997 Oct; 39(5):626-7. PubMed ID: 9363666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
    Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
    Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients.
    Khosroshahi HT; Asghari A; Estakhr R; Baiaz B; Ardalan MR; Shoja MM
    Transplant Proc; 2006 Sep; 38(7):2077-9. PubMed ID: 16980004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPLC analysis of azathioprine metabolites in red blood cells, plasma and urine in renal transplant recipients.
    Weller S; Thürmann P; Rietbrock N; Gossmann J; Scheuermann EH
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):639-45. PubMed ID: 8963480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance?
    Cruz DN; Perazella MA; Abu-Alfa AK; Mahnensmith RL
    Am J Kidney Dis; 1996 Oct; 28(4):535-40. PubMed ID: 8840943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
    Pisani F; Tisone G; Alciati E; Vennarecci G; Pieragostini E; Casciani CU
    Transplant Proc; 1994 Oct; 26(5):2602-3. PubMed ID: 7940809
    [No Abstract]   [Full Text] [Related]  

  • 16. Anemia due to coadministration of renin-angiotensin-system inhibitors and PPARγ agonists in uncomplicated diabetic patients.
    Raptis AE; Bacharaki D; Mazioti M; Marathias KP; Markakis KP; Raptis SA; Dimitriadis GD; Vlahakos DV
    Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):416-9. PubMed ID: 22441720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril-associated anemia in renal transplant recipients treated for hypertension.
    Vlahakos DV; Canzanello VJ; Madaio MP; Madias NE
    Am J Kidney Dis; 1991 Feb; 17(2):199-205. PubMed ID: 1992663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation.
    Sinnamon KT; Courtney AE; Maxwell AP; McNamee PT; Savage G; Fogarty DG
    Nephrol Dial Transplant; 2007 Jul; 22(7):1969-73. PubMed ID: 17353209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors slow recovery from anemia following cardiac surgery.
    Ripamonti V; Racca V; Calvo MG; Castiglioni P; Ferratini M
    Chest; 2006 Jul; 130(1):79-84. PubMed ID: 16840386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period.
    Formica RN; Friedman AL; Lorber MI; Bia MJ
    Transplant Proc; 2004 Nov; 36(9):2675-8. PubMed ID: 15621121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.